| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/28/2011 | WO2011047481A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098441 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
| 04/28/2011 | US20110098278 Galantamine amino acid and peptide prodrugs and uses thereof |
| 04/28/2011 | US20110098277 Fab I Inhibitors |
| 04/28/2011 | US20110098241 Rapamycin analogs as anti-cancer agents |
| 04/28/2011 | US20110098237 Methods for inhibiting drug degradation |
| 04/28/2011 | US20110097305 Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Cell Cycle Inhibitors |
| 04/28/2011 | CA2778384A1 Glycoside derivative and uses thereof |
| 04/28/2011 | CA2776914A1 Diazepan derivatives as modulators of chemokine receptors |
| 04/27/2011 | EP2314590A1 Substituted quinolones and methods of use |
| 04/27/2011 | EP2314587A1 Nitrogenated heterocyclic compound |
| 04/27/2011 | EP2314295A1 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 04/27/2011 | EP2313416A2 Synthetic intermediates and processes |
| 04/27/2011 | EP2313370A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 04/27/2011 | CN102036994A Time temperature indicator comprising indolenin based spiropyrans containing N-acetylamido or N-acetylester side chain |
| 04/27/2011 | CN102036967A Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists |
| 04/27/2011 | CN102030756A 6,7-methylene-dioxy-1,2,3,4-tetrahydroisoquinoline derivative and preparation method and application thereof |
| 04/27/2011 | CN101575341B Amidocyanogen amido xanthone pyridine derivant, and preparation method and application thereof |
| 04/27/2011 | CN101492455B Optical pure levorotation cephalotaxine and separation purification method |
| 04/27/2011 | CN101468991B Isoquinolinium compound or its salt, pharmaceutical composition containing the same, preparation and use thereof |
| 04/26/2011 | US7932272 Antifungal agent containing heterocyclic compound |
| 04/26/2011 | US7932259 Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group |
| 04/26/2011 | US7932250 Thienopyrazole derivative having PDE7 inhibitory activity |
| 04/26/2011 | CA2500952C Neurologically-active compounds |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2353554C Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 04/21/2011 | WO2011047174A1 Synthetic methods for spiro-oxindole compounds |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011045265A2 Spirocyclic derivatives as histone deacetylase inhibitors |
| 04/21/2011 | WO2010150281A3 Novel azabicyclohexanes |
| 04/21/2011 | WO2010149727A3 Injectable formulations containing asenapine and method of treatment using same |
| 04/21/2011 | US20110092706 Process for the manufacture of enantiomerically pure aryloctanoic acids as aliskiren |
| 04/21/2011 | US20110092700 Novel Coumarin Derivative Having Antitumor Activity |
| 04/21/2011 | US20110092559 Pyrrole and pyrazole daao inhibitors |
| 04/21/2011 | US20110092530 Cyclopamine tartrate salt and uses thereof |
| 04/21/2011 | US20110092529 1,2,4-Triazole Derivatives and Their Use as Oxytocin Antagonists |
| 04/21/2011 | US20110092475 2-substituted-ethynylthiazole derivatives and uses of same |
| 04/21/2011 | US20110092459 Alpha helix mimetics and methods relating thereto |
| 04/21/2011 | US20110092415 Anti-Viral Compounds |
| 04/21/2011 | US20110092368 2,4,6-Phenyl-substituted cyclic ketoenols |
| 04/21/2011 | CA2777543A1 Synthetic methods for spiro-oxindole compounds |
| 04/21/2011 | CA2777113A1 Spirocyclic derivatives as histone deacetylase inhibitors |
| 04/20/2011 | EP2311840A1 Spirocyclic derivatives as histone deacetylase inhibitors |
| 04/20/2011 | EP2311463A1 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 04/20/2011 | EP2311460A1 Oxymorphone controlled release formulations |
| 04/20/2011 | EP2310014A1 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 04/20/2011 | EP2016081B1 Anti-viral pyrimidine nucleoside derivatives |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | CN1955183B 20-bit esterified camptothecine derivate, its preparation method and drug composite and use |
| 04/20/2011 | CN102026998A Spirocyclic derivatives as histone deacetylase inhibitors |
| 04/20/2011 | CN102026990A Novel inhibitors of hepatitis c virus replication |
| 04/20/2011 | CN102026972A New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 04/20/2011 | CN102026969A Novel N-(2-amino-phenyl)-acrylamides |
| 04/20/2011 | CN102020985A Method for manufacturing novel dendritic fluorescent chemosensor and application |
| 04/20/2011 | CN102020657A Condensed heteroaryl derivative, and preparation method and application thereof |
| 04/20/2011 | CN102020654A Method for extracting stephanine from stephania |
| 04/20/2011 | CN102020653A New application of amino perhydrogenated quinazoline compound and derivative preparation thereof for improving drug effects of anticancer drugs |
| 04/20/2011 | CN102020652A Method for preparing cycleanine |
| 04/20/2011 | CN102020651A 6-aryl amino pyridone formamide MEK (methyl ethyl ketone) inhibitor |
| 04/19/2011 | US7928235 Methods of making esters of camptothecins |
| 04/19/2011 | US7928209 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928037 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 04/19/2011 | CA2516643C Method for preparing polymorphism of irinotecan hydrochloride |
| 04/19/2011 | CA2464951C Spirocyclic 3-phenyl-3-substituted-4-ketolactams and -lactones |
| 04/14/2011 | WO2011043445A1 1-substituted-trans-3-(substituted amino)piperidin-4-ol |
| 04/14/2011 | WO2011043387A1 Pyrazoloxazole compound |
| 04/14/2011 | WO2011042399A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists |
| 04/14/2011 | WO2011017634A8 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 04/14/2011 | US20110087027 Synthetic methods for spiro-oxindole compounds |
| 04/14/2011 | US20110086871 Rifaximin compositions and method of use |
| 04/14/2011 | US20110086851 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086762 4'4'-Dioxaspiro-Spirocyclically Substituted Tetramates |
| 04/14/2011 | CA2777209A1 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems |
| 04/14/2011 | CA2774215A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists |
| 04/13/2011 | EP2308880A1 Tetracyclic compound |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308848A1 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP2307422A1 Novel spirochromanone carboxylic acids |
| 04/13/2011 | EP1931636B1 Isoquinolines as igf-1r inhibitors |
| 04/13/2011 | CN102015680A New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 04/13/2011 | CN102015651A Compounds and compositions as TLR activity modulators |
| 04/13/2011 | CN102015641A Heterocyclic compound |
| 04/13/2011 | CN102010418A High-camptothecin compounds and use thereof as medicaments |
| 04/13/2011 | CN102010417A Sanguinarine derivatives and synthesis method and use thereof |
| 04/13/2011 | CN102010416A Substituted tetrahydroquinolines |
| 04/12/2011 | CA2446221C Stable powder inhalation dosage formulation |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/07/2011 | WO2011041143A1 HETEROCYCLIC-FUSED PYRAZOLO[4,3-c]PYRIDIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS |
| 04/07/2011 | US20110082294 Novel bicyclic compounds |
| 04/07/2011 | US20110082158 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 04/07/2011 | US20110082144 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 04/07/2011 | US20110082132 [4-(1-amino-ehtyl) - cyclohexyl] -methyl-amine and [6-(1-amino-ehtyl) -tetrahydro-pyran-3-yl] -methyl-amine derivatives as antibacterials |